
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1007 | 1071 | 1117 | 795 | 805 | - |
Fund Return | 0.71% | 7.13% | 11.72% | -7.35% | -4.24% | - |
Place in category | - | - | - | - | - | - |
% in Category | - | - | - | - | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Mandarine Unique Small Mid Caps Eg | 161.6M | 3.20 | 0.16 | 4.45 | ||
Mandarine Unique Small Mid Caps Ei | 161.6M | 3.20 | 0.16 | 4.45 | ||
Mandarine Unique Small Mid Caps Em | 161.6M | 3.25 | 0.47 | 4.78 | ||
Mandarine Unique Small Mid Caps Er | 161.6M | 3.02 | -0.88 | 3.25 | ||
Mandarine Unique Small Mid Caps Ee | 161.6M | 2.78 | -1.03 | 2.97 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Invesco JapEqAdvantage A EUR H AccE | 57.05B | -1.95 | 10.69 | 6.70 | ||
Invesco JapEqAdvantage C EUR H AccE | 57.05B | -1.82 | 11.66 | 7.54 | ||
LU1482751903 | 385.28M | 1.06 | 12.91 | - | ||
LU1841614867 | 232.62M | 0.91 | 11.92 | - | ||
Morgan Stanley Global Brands AH | 18.49B | 3.53 | 2.71 | 6.90 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Natera Inc | US6323071042 | 4.16 | 138.26 | +3.28% | |
Xometry Inc Ordinary Shares - Class A | - | 3.80 | - | - | |
Agilysys | US00847J1051 | 3.69 | 67.19 | -3.11% | |
Guidewire | US40171V1008 | 3.54 | 175.36 | +0.64% | |
Q2 Holdings | US74736L1098 | 3.54 | 69.17 | -1.62% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Strong Sell |
Technical Indicators | Strong Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review